SCHEMBL7804354

SCHEMBL7804354

CC(C)(Oc1ccc(C2CCN(C(=O)c3cccs3)CC2)cc1)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.58
NPC1 O15118 1/20 0.58
RAB9A P51151 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
KCNA5 P22460 2/20 0.50
ALDH1A1 P00352 6/20 0.49
CCR5 P51681 1/20 0.48
HSD17B10 Q99714 2/20 0.47
PDE4B Q07343 1/20 0.47
GAA P10253 1/20 0.47
PABPC1 P11940 1/20 0.47
EIF4H Q15056 1/20 0.47
CYP3A4 P08684 1/20 0.46
HTT P42858 2/20 0.46
TSHR P16473 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
KDM4E B2RXH2 1/20 0.46
THRB P10828 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
EGLN1 Q9GZT9 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7810746 0.89 BCL9 (0.56) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7810069 0.83 HSD11B1 (0.59) NPC1RAB9AALDH1A1TSHRMEN1
SCHEMBL7804301 0.82 KCNA5 (0.73) MAPTKCNA5ALDH1A1GAAHTT
SCHEMBL7814130 0.81 LMNA (0.54) ALDH1A1GAATSHRKDM4EEGLN1
SCHEMBL27303865 0.81 MAPT (0.84) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7813604 0.80 HSP90AA1 (0.46) MAPTCYP3A4TSHREGLN1MEN1
SCHEMBL7804429 0.79 HSD11B1 (0.66) SMN1; SMN2ALDH1A1GAAEGLN1LMNA
SCHEMBL7810206 0.79 HSD11B1 (0.54) SMN1; SMN2ALDH1A1GAATSHREGLN1
SCHEMBL7810110 0.78 HSD11B1 (0.51) GAATSHREGLN1MEN1KMT2A
SCHEMBL7817580 0.78 RAB9A (0.58) NPC1RAB9ASMN1; SMN2ALDH1A1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed